Lipids and skin barrier function--a clinical perspective.
The stratum corneum (SC) protects us from dehydration and external dangers. Much is known about the morphology of the SC and penetration of drugs through it, but the data are mainly derived from in vitro and animal experiments. In contrast, only a few studies have the human SC lipids as their focus and in particular, the role of barrier function in the pathogenesis of skin disease and its subsequent treatment protocols. The 3 major lipids in the SC of importance are ceramides, free fatty acids, and cholesterol. Human studies comparing levels of the major SC lipids in patients with atopic dermatitis and healthy controls have suggested a possible role for ceramide 1 and to some extent ceramide 3 in the pathogenesis of the disease. Therapies used in diseases involving barrier disruption have been sparely investigated from a lipid perspective. It has been suggested that ultraviolet light as a treatment increases the amount of all 3 major SC lipids, while topical glucocorticoids may lead to a decrease. Such effects may influence the clinical outcome of treatment in diseases with impaired barrier function. We have, therefore, conducted a review of the literature on SC lipids from a clinical perspective. It may be concluded that the number of human studies is very limited, and in the perspective of how important diseases of impaired barrier function are in dermatology, further research is needed.
Jungersted
Jakob Mutanu
JM
Department of Dermatology, Roskilde Hospital, University of Copenhagen, Køgevej 7-13, DK-4000 Roskilde, Denmark. rsjamu@ra.dk
Hellgren
Lars I
LI
Jemec
Gregor B E
GB
Agner
Tove
T
D000818:Animals; D002518:Ceramides / Q000737:chemistry / Q000378:metabolism*; D002784:Cholesterol / Q000378:metabolism*; D003876:Dermatitis, Atopic / Q000378:metabolism / Q000503:physiopathology; D003877:Dermatitis, Contact / Q000378:metabolism / Q000503:physiopathology; D004817:Epidermis / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism* / Q000528:radiation effects; D005230:Fatty Acids, Nonesterified / Q000378:metabolism*; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D012879:Skin Physiological Phenomena; D014467:Ultraviolet Therapy; D014870:Water Loss, Insensible / Q000502:physiology
D002518:Ceramides; D005230:Fatty Acids, Nonesterified; D005938:Glucocorticoids; D002784:Cholesterol